Welcome to Novartis
The laptop was the first sign.
Jeff walked in the room, saw my MacBook Pro, laughed, and suggested I might want to hide it. “Oh no”, I thought. “I’m interviewing at one of those companies that has corporate-enforced Windows.”
Oh my. Little did I know.
Before I joined Novartis, I had an idealized set of expectations about the information environment that I would find here. As a big pharma, we’d be dependent on innovation and technology to keep the drug pipeline full, the money flowing, and the patient’s needs addressed - and we’d have the resources to really tackle the problem. So, I thought, Novartis must have an incredibly rich and productive information space behind the firewall, because that kind of environment is necessary for us to remain in business!
What would I find, I imagined?
My list looked something like this:
- Easy access to information - both internally across the company, and outside from the larger research world - because it’s at the foundation of research today.
- State-of-the-art analysis tools that let you dig through the mounds of data that everyone is creating.
- A culture of information sharing, where perhaps the Intranet would be even more useful than the web.
- Powerful search tools.
- Productive cross-organization collaboration between corporate IT, scientific IT, and scientific informatics, because, after all, we all share in the success of the company.
- An IT culture of curiosity, exploration, and pilots.
- Scientists, who often dig this kind of thing, always using the latest technologies to make themselves both professionally and personally more productive.
- A barely-contained exciting chaos of technical innovation accelerating us past our competitors.
…
Well, imagine my surprise at where we really are.
Most of the scientists and IT folk that I have talked to in NIBR have expressed exactly the same thing.
At some point on this blog, I will probably cover the topic IT Strategy. A strategy is used to define where we need to be in the future (usually 3-5 years) based on business priorities and technical possibilities. Discussions of corporate IT strategy are beginning, and we’re beginning to tune the NIBR IT strategy as well.
Meanwhile, I know where we should be now - it’s where I thought we would already be. Let’s get there as fast as we can so that the IT strategy can indeed be reaching into the future, where Novartis needs us to be.